Blogroll
Glenmark to conduct trials in India for potential COVID-19 drug
Glenmark Pharmaceuticals Ltd said on Thursday it will start clinical trials in India of antiviral drug favipiravir, seen as a potential treatment for COVID-19, sending its shares up as much as 9%.
Categories: Health
Exclusive: Finance, tech firms on hiring spree amid coronavirus turmoil - LinkedIn
The coronavirus is roiling global job markets, but the picture is not all gloomy. Finance, technology and consumer goods firms are hiring tens of thousands in the United States and other countries, according to data from Microsoft Corp's professional networking site LinkedIn.
Categories: Technology
Proximus gets temporary 5G licence, posts net income beat
Belgian telephone, internet and television service provider Proximus reported higher than expected first-quarter net profit on Thursday, and said market regulator BIPT has granted it and four other companies temporary 5G licences.
Categories: Technology
Orange's French business picks up despite virus outbreak
A turnaround in France helped Orange post growing first quarter revenues, though store closures in Europe during the coronavirus outbreak dented equipment sales and hindered efforts to roll out new fibre optic broadband connections.
Categories: Technology
SoftBank to write down WeWork by $6.6 billion, compounding portfolio misery
SoftBank Group Corp said it sees a loss of around 700 billion yen ($6.6 billion) for the year ended March on the portion of its WeWork investment held outside the Vision Fund, as the virus compounds woes at one of the firm's biggest bets.
Categories: Technology
Swisscom warns curbs on antenna upgrade stalling 5G rollout; keeps 2020 outlook
State-controlled telecoms group Swisscom AG said on Thursday that the rollout of its new fifth-generation (5G) mobile technology was getting stalled due to the governments' resistance to installing upgraded antennas.
Categories: Technology
Nintendo seen extending profit streak as housebound consumers switch on
Japan's Nintendo Co Ltd is expected to extend its decade-high earnings streak when it reports fourth-quarter results next week, powered by the hit Switch console which is expanding its reach among locked-down consumers.
Categories: Technology
Data on Gilead drug raises hopes in pandemic fight, Fauci calls it 'highly significant'
The top U.S. infectious disease official said Gilead Sciences Inc's experimental antiviral drug remdesivir will become the standard of care for COVID-19 after early clinical trial results on Wednesday showed it helped patients recover more quickly from the illness caused by the coronavirus.
Categories: Health
Exclusive: Amazon turns to Chinese firm on U.S. blacklist to meet thermal camera needs
Amazon.com Inc has bought cameras to take temperatures of workers during the coronavirus pandemic from a firm the United States blacklisted over allegations it helped China detain and monitor Uighurs and other Muslim minorities, three people familiar with the matter told Reuters.
Categories: Technology
Explainer: What does new data say about Gilead's experimental coronavirus drug?
New clinical data on Gilead Sciences Inc's experimental antiviral drug remdesivir has raised hopes it might be an effective treatment for the novel coronavirus that has infected more than 3 million people and killed over 225,000 worldwide.
Categories: Health
FDA may announce emergency use of Gilead's coronavirus drug on Wednesday: NYT
U.S. drug regulators may announce their decision allowing emergency use of Gilead Science Inc's experimental coronavirus drug remdesivir as soon as Wednesday, the New York Times reported, citing an unnamed senior administration official.
Categories: Health
Trump, Fauci see hope with Gilead's drug in coronavirus fight
U.S. President Donald Trump on Wednesday greeted as good news reports that a Gilead Sciences Inc experimental antiviral drug might help fight the coronavirus, and infectious disease official Anthony Fauci said data shows it appears to help patients hospitalized with COVID-19.
Categories: Health
WHO declines comment on remdesivir in COVID-19, hopes for best
A top World Health Organization official declined comment on Wednesday on reports that Gilead Science's remdesivir could help treat COVID-19, the respiratory disease caused by the novel coronavirus, but said that further data was needed.
Categories: Health
South Korea reports no new domestic coronavirus cases, first time since Feb peak
South Korea reported on Thursday no new domestic coronavirus cases for the first time since its Feb. 29 peak, the Korea Centers for Disease Control and Prevention (KCDC) said.
Categories: Health
Facebook sees 'signs of stability' in ad spending after coronavirus drop
Facebook Inc beat analysts' estimates for quarterly revenue on Wednesday and said it has seen "signs of stability" for sales in April after a plunge in March, in yet another signal that tech giants may weather the coronavirus-induced economic collapse better than other sectors.
Categories: Technology
Yemen reports first two deaths from coronavirus
Yemen has reported its first two deaths from the novel coronavirus, its health minister told Yemen TV late on Wednesday.
Categories: Health
SoftBank sees $8.4 billion net loss on WeWork writedown
SoftBank Group Corp said it sees a loss of around 700 billion yen ($6.6 billion) in the year ending March on the portion of its WeWork investment held outside the Vision Fund, extending the group's expected net loss to 900 billion yen.
Categories: Technology
China reports 4 new coronavirus cases vs 22 a day earlier
China reported four new coronavirus cases for April 29, down from 22 a day earlier, data from the country's health authority showed.
Categories: Health
Mexico coronavirus infections rise to 17,799 cases and 1,732 deaths
Mexico's health ministry on Wednesday reported 1,047 new confirmed cases of coronavirus infection and 163 additional fatalities, bringing the total in the country to 17,799 cases and 1,732 deaths.
Categories: Health
Panama coronavirus cases climb to 6,378, deaths reach 178
Confirmed cases of coronavirus infection in Panama reached 6,378 on Wednesday, a rise of 178 from the previous day, and deaths climbed by two to 178, the health ministry said.
Categories: Health